Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
Takeda pushes one narcolepsy program into phase III, discontinues another
Zimmer Biomet to cut about 540 jobs
Moderna shares slide as longer-term data shows quick fall in RSV vaccine efficacy
*please scroll down for all the latest news*